T-cell receptor/CD28-targeted immunotherapeutics selectively drive naive T-cell expansion to generate functional HIV-specific responses.

Saved in:
Bibliographic Details
Title: T-cell receptor/CD28-targeted immunotherapeutics selectively drive naive T-cell expansion to generate functional HIV-specific responses.
Authors: Mueller AL; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA., Lamcaj S; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA., Garforth S; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA., Hiner C; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA., Woodley D; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA., Paraiso K; Cellecta, Inc., Mountain View, California, USA., Mi T; Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Low S; Cue Biopharma, Boston, Massachusetts, USA., Youngblood B; Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Almo SC; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA., Goldstein H; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA.
Source: Journal of virology [J Virol] 2025 Sep 23; Vol. 99 (9), pp. e0018825. Date of Electronic Publication: 2025 Aug 05.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-5514
DOI:10.1128/jvi.00188-25